June 2010 Research News


Lack of Insurance Affects African Americans’ Breast Cancer Prognosis More Than Whites’
June 25, 2010
Research suggests that having no or inadequate health insurance makes a bigger difference in breast cancer prognosis for African American women compared to white women. Read more...

Optical Tomography May Help Assess Suspicious Areas in Breast
June 24, 2010
Research suggests that optical tomography may be able to help determine if a suspicious area in the breast is cancer or not. Read more...

Some Parents Who’ve Been Tested Support Abnormal Breast Cancer Gene Testing for Kids
June 22, 2010
About a third of people who were tested for abnormal breast cancer genes (BRCA1 or BRCA2), supported the same testing for their children. Read more...

Oral Bisphosphonates May Reduce Risk for Postmenopausal Women
June 22, 2010
Two studies suggest that oral bisphosphonates may reduce the risk of invasive breast cancer in postmenopausal women by 30% to 40%. Read more...

New Technique May Find Heart Damage Earlier
June 13, 2010
Research suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional measurement tests. Read more...

HER2-Positive Breast Cancer May Respond to Experimental Treatments
June 8, 2010
Early results from a very early study suggests that some advanced-stage, HER2-positive breast cancers that have stopped responding to Herceptin may respond to the experimental treatment T-DM1. Read more...

Olaparib May Help Treat Triple-Negative Breast Cancer
June 8, 2010
Research suggests that combining the experimental targeted therapy olaparib with a taxane chemotherapy may be effective against triple-negative breast cancer. Read more...

Axillary Lymph Node Removal May Not Make Sense for Most Women
June 8, 2010
Research suggests that routinely removing multiple underarm (axillary) lymph nodes during early-stage breast cancer surgery may not make sense for most women. Read more...

Afinitor May Make Metastatic Breast Cancer Start Responding to Other Medicines Again
June 7, 2010
A small, early study suggests that Afinitor, a targeted therapy medicine, can make HER2-positive, metastatic breast cancers that have stopped responding to Herceptin and Taxol start responding to those treatments again. Read more...

Adding Avastin to Chemo Stops Metastatic Cancer From Growing
June 7, 2010
Adding Avastin to any of several common chemotherapy regimens for metastatic, HER2-negative breast cancer seems to lengthen the time before the cancer grows compared to the same regimen without Avastin. Read more...

Biopsy of Metastatic Cancer May Change Treatment Plan
June 7, 2010
Research suggests that a breast cancer's characteristics may change if the cancer metastasizes, so doing a biopsy on metastatic cancer may make sense in some cases. Read more...

Eribulin May Be Treatment Option for Metastatic Breast Cancer
June 6, 2010
Research suggests that eribulin, an experimental chemotherapy medicine, may be a good treatment option for metastatic breast cancer that has stopped responding to other treatments. Read more...

Experimental Combo Shows Promise for Treating Metastatic HER2-Positive Cancer
June 6, 2010
A very small, very early study suggests that a combination of Herceptin and Afinitor may help treat HER2-positive, metastatic breast cancers that have stopped responding to many other treatments. Read more...

Retesting Metastatic Cancer’s HER2 Status Can Predict Response to Experimental Medicine
June 5, 2010
Retesting metastatic breast cancer for HER2 status -- to see if the cancer is still HER2-positive -- can help figure out if the cancer is more or less likely to respond to T-DM1, an experimental targeted therapy medicine. Read more...

Intraoperative Radiation May Work as Well as Standard Delivery Method
June 5, 2010
Research suggests that intraoperative radiation therapy and traditional external beam radiation are equally effective and safe. Read more...

Giving Chemo Medicines Sequentially May Have Advantages
June 2, 2010
Treating early-stage breast cancer with two chemotherapy medicines followed by a third seems to have some advantages compared to giving two or three medicines at the same time, but may cause more severe side effects. Read more...

Prolia Approved to Treat Osteoporosis
June 2, 2010
A new osteoporosis treatment called Prolia has been approved by the U.S. Food and Drug Administration. Read more...

Was this resource helpful?

Yes No
C3a
C3b
Evergreen-donate
Back to Top